10x Genomics, Inc. Ratios

Ratios Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 85.14%80.41%75.18%80.44%84.89%76.69%66.15%67.86%
EBT Margin -26.36%-76.82%-12.62%-178.85%-10.95%-31.36%-40.21%-29.09%
EBIT Margin -25.85%-75.70%-12.43%-178.74%-10.65%-32.52%-42.88%-31.85%
EBITDA Margin -26.41%-76.89%-12.71%-181.61%-11.86%-32.52%-42.88%-31.85%
Operating Margin -25.85%-75.70%-12.43%-178.74%-10.65%-32.52%-42.88%-31.85%
Net Margin -26.39%-76.88%-12.71%-181.62%-11.87%-32.15%-41.23%-29.90%
FCF Margin -20.33%-56.52%-3.30%-85.18%-25.01%-32.00%-10.31%-0.94%
Efficiency
Inventory Average 0.01B0.02B0.04B0.07B0.08B0.08B
Assets Average 0.37B0.77B0.97B1.02B1.00B0.94B
Equity Average 0.10B0.58B0.78B0.81B0.77B0.73B
Invested Capital -0.22B0.43B0.74B0.82B0.81B0.74B0.71B
Asset Utilization Ratio 0.670.390.500.500.620.65
Leverage & Solvency
Interest Coverage Ratio -22.66-45.98-9.93-317.56-60.34-352.82-0.00B-0.00B
Debt to Equity -0.130.07
Debt Ratio 0.240.05
Equity Ratio -1.770.690.800.800.780.770.77
Times Interest Earned -22.66-45.98-9.93-317.56-60.34-352.82-0.00B-0.00B
Valuation
Enterprise Value -0.07B6.91B14.56B16.05B3.74B6.23B1.34B
Market Capitalization 7.33B15.24B16.64B4.17B6.61B1.74B
Return Ratios
Return on Sales -0.26%-0.77%-0.13%-1.82%-0.12%-0.32%-0.41%-0.30%
Return on Capital Employed -0.10%-0.82%-0.06%-0.19%-0.31%-0.24%
Return on Assets -0.09%-0.71%-0.06%-0.16%-0.26%-0.19%
Return on Equity -0.31%-0.94%-0.07%-0.20%-0.33%-0.25%